RegsWizard - Simplifying the Complex World of Medical Device Regulation

RegsWizard - 简化医疗器械监管的复杂世界

基本信息

  • 批准号:
    10020764
  • 负责人:
  • 金额:
    $ 50.04万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Collaborative R&D
  • 财政年份:
    2021
  • 资助国家:
    英国
  • 起止时间:
    2021 至 无数据
  • 项目状态:
    已结题

项目摘要

**The** **Challenge**The world of Medical Device Regulation ("MDRegs") is extremely complex and difficult to navigate. Even seemingly simple questions like, "is my product a Medical Device ("MD")" are riven with interpretive complexity and nuance. This is even more the case in the emerging world of Digital Health which is contributing significantly to the increase in the number of Software as a Medical Device ("SAMD").The guidance available to product owners ("Product-Owners") looking to navigate this space, is limited to generic 'static' advice and information provided by relevant industry bodies (i.e. regulators or approved assessment bodies like BSI/TuvSud) or very specialist consultancy support from rare and costly experts.This limited guidance is exacerbated by a lack of transparency or clarity over the precise interpretations to be applied - particularly in the SAMD space - and the associated requirements that Product-Owners need to take into account to ensure compliance.The full impact of this is to be found in the raft of products that do not - intentionally or otherwise - meet these key regulatory requirements (a recent ORCHA survey illustrated a potential none compliance rate in the Digital health space of over 50%), but also huge inefficiency and delay for those Product-Owners who attempt to navigate through the complexities.**The Concept**This project brings together a hugely complimentary and multi-disciplinary team, lead by ORCHA to address this critical issue through the development of an intuitive, interactive and intelligent tool (the "RegsWizard"), that can provide Product-Owners with tailored, personalised and reliable advice and guidance at a fraction of the cost of traditional 'expert' consultancies.The RegsWizard is a ground breaking concept in this space - although ORCHA have developed similar constructs in the broader Digital health regulatory environment. It will revolutionise the navigation of products through the MDRegs landscape and ensure that reliable advice and guidance is available to all Product-Owners at an affordable price.At the heart of the RegsWizard concept is an intuitive interactive tool that enables Product-Owners to accurately identify the likely status of their product under MDRegs in the UK (UKCA mark) and EU (MDR CE mark) and which generates a tailored checklist of compliance requirements that flow from that status and which will be necessary to meet the demands of the relevant regime. The RegsWizard will also identify or map to relevant externally maintained Nomenclatures with a specific focus on SNOMED and GMDN.
* 挑战 ** 医疗器械法规(“MDRegs”)的世界极其复杂,难以驾驭。即使是看似简单的问题,如“我的产品是医疗器械(“MD”)”,也充满了解释的复杂性和细微差别。在新兴的数字健康领域,情况更是如此,数字健康对作为医疗器械的软件(“SAMD”)数量的增加做出了重大贡献。(“产品所有者”)希望在这个领域中导航,仅限于相关行业机构提供的一般“静态”建议和信息(即监管机构或批准的评估机构,如BSI/TuvSud)或来自罕见且昂贵的专家的非常专业的咨询支持。这种有限的指导由于对所应用的精确解释缺乏透明度或清晰度而加剧-特别是在SAMD领域-以及产品所有者为确保合规性而需要考虑的相关要求。这一点的全部影响将在有意或无意地不符合这些关键监管要求的大量产品中发现(最近的一项ORCHA调查显示,数字健康领域的潜在不遵守率超过50%),但对于那些试图通过复杂性导航的产品所有者来说,也是巨大的效率和延迟。概念 ** 这个项目汇集了一个巨大的互补和多学科的团队,由ORCHA领导,通过开发一个直观,互动和智能的工具来解决这个关键问题(“RegsWizard”),可以为产品所有者提供定制的,个性化和可靠的建议和指导的一小部分成本的传统'专家'咨询。RegsWizard是一个突破性的概念,在这个领域-尽管ORCHA已经在更广泛的数字健康监管环境中开发了类似的结构。它将彻底改变产品在MDRegs环境中的导航,并确保以合理的价格向所有产品所有者提供可靠的建议和指导。RegsWizard概念的核心是一个直观的交互式工具,使产品所有者能够准确地识别其产品在英国MDRegs下的可能状态(UKCA标志)和欧盟(MDR CE标志),并生成一个量身定制的合规要求清单,这些要求来自该状态,并且是满足相关制度要求所必需的。RegsWizard还将识别或映射到外部维护的相关术语,特别关注SNOMED和GMDN。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

其他文献

吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
生命分子工学・海洋生命工学研究室
生物分子工程/海洋生物技术实验室
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:

的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('', 18)}}的其他基金

An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
  • 批准号:
    2901954
  • 财政年份:
    2028
  • 资助金额:
    $ 50.04万
  • 项目类别:
    Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
  • 批准号:
    2896097
  • 财政年份:
    2027
  • 资助金额:
    $ 50.04万
  • 项目类别:
    Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
  • 批准号:
    2780268
  • 财政年份:
    2027
  • 资助金额:
    $ 50.04万
  • 项目类别:
    Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
  • 批准号:
    2908918
  • 财政年份:
    2027
  • 资助金额:
    $ 50.04万
  • 项目类别:
    Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
  • 批准号:
    2908693
  • 财政年份:
    2027
  • 资助金额:
    $ 50.04万
  • 项目类别:
    Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
  • 批准号:
    2908917
  • 财政年份:
    2027
  • 资助金额:
    $ 50.04万
  • 项目类别:
    Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
  • 批准号:
    2879438
  • 财政年份:
    2027
  • 资助金额:
    $ 50.04万
  • 项目类别:
    Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
  • 批准号:
    2890513
  • 财政年份:
    2027
  • 资助金额:
    $ 50.04万
  • 项目类别:
    Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
  • 批准号:
    2879865
  • 财政年份:
    2027
  • 资助金额:
    $ 50.04万
  • 项目类别:
    Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
  • 批准号:
    2876993
  • 财政年份:
    2027
  • 资助金额:
    $ 50.04万
  • 项目类别:
    Studentship

相似海外基金

III: Small: Query-By-Sketch: Simplifying Video Clip Retrieval Through A Visual Query Paradigm
III:小:按草图查询:通过可视化查询范式简化视频剪辑检索
  • 批准号:
    2335881
  • 财政年份:
    2024
  • 资助金额:
    $ 50.04万
  • 项目类别:
    Standard Grant
Collaborative Research: FMitF: Track I: Simplifying End-to-End Verification of High-Performance Distributed Systems
合作研究:FMitF:第一轨:简化高性能分布式系统的端到端验证
  • 批准号:
    2318954
  • 财政年份:
    2023
  • 资助金额:
    $ 50.04万
  • 项目类别:
    Standard Grant
Collaborative Research: FMitF: Track I: Simplifying End-to-End Verification of High-Performance Distributed Systems
合作研究:FMitF:第一轨:简化高性能分布式系统的端到端验证
  • 批准号:
    2318953
  • 财政年份:
    2023
  • 资助金额:
    $ 50.04万
  • 项目类别:
    Standard Grant
Simplifying quantum computing: from theory to applications
简化量子计算:从理论到应用
  • 批准号:
    EP/W028301/1
  • 财政年份:
    2023
  • 资助金额:
    $ 50.04万
  • 项目类别:
    Fellowship
SBIR Phase II: Simplifying the use of recycled plastics in film extrusion
SBIR 第二阶段:简化薄膜挤出中再生塑料的使用
  • 批准号:
    2212917
  • 财政年份:
    2023
  • 资助金额:
    $ 50.04万
  • 项目类别:
    Cooperative Agreement
Simplifying and commercialising a portion controlled container and app to assist people looking to attempting to limit snack or alcohol intake
简化并商业化份量控制容器和应用程序,以帮助人们尝试限制零食或酒精摄入量
  • 批准号:
    10046597
  • 财政年份:
    2022
  • 资助金额:
    $ 50.04万
  • 项目类别:
    Grant for R&D
Simplifying Processes in the Offshore Decommissioning sector: Reducing P&A costs by 30% and emissions by 50%
简化海上退役部门的流程:减少 P
  • 批准号:
    10035208
  • 财政年份:
    2022
  • 资助金额:
    $ 50.04万
  • 项目类别:
    Collaborative R&D
Simplifying complexity and diversity of circadian clocks
简化生物钟的复杂性和多样性
  • 批准号:
    22H04984
  • 财政年份:
    2022
  • 资助金额:
    $ 50.04万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Elements: Simplifying Compiled Python Packaging in the Sciences
元素:简化科学领域的已编译 Python 打包
  • 批准号:
    2209877
  • 财政年份:
    2022
  • 资助金额:
    $ 50.04万
  • 项目类别:
    Standard Grant
Simplifying health and wellness by connecting multiple data points from smart devices and turning them into insights
通过连接来自智能设备的多个数据点并将其转化为见解来简化健康和保健
  • 批准号:
    10046078
  • 财政年份:
    2022
  • 资助金额:
    $ 50.04万
  • 项目类别:
    Grant for R&D
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了